TET2 and acute myeloid leukemia: A similar pattern of TET2 dysregulation has been observed in hematological malignancies, particularly in AML, a setting in which TET2 mutations are frequent38 and contribute to leukemia stem cell (LSC) generation, expansion, and maintenance.